Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension
- PMID: 29121072
- PMCID: PMC5679547
- DOI: 10.1371/journal.pone.0187806
Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension
Abstract
Background: Serial assessment of right ventricular ejection fraction (RVEF) predicts the clinical outcome of patients with pulmonary hypertension (PH). Cardiac magnetic resonance imaging (CMRI) enables RVEF monitoring, but its applicability is limited in clinical practice. This study aimed to examine the correlation between changes in CMRI-derived RVEF with those in echocardiographic indices in patients with precapillary PH.
Methods: CMRI and echocardiographic indices of RV systolic function were evaluated at baseline and follow-up in 54 consecutive patients with precapillary PH (pulmonary arterial hypertension (PAH), n = 23; non-PAH, n = 31). During follow-up, medical treatment was optimized according to the guidelines for PH. Using CMRI-derived RVEF as the gold standard, we examined the accuracy of five echocardiographic indices by correlation analysis and receiver operating characteristic (ROC) analysis and by calculating sensitivity, specificity, and positive and negative predictive values.
Results: After an average period of 9.5 months, CMRI-derived RVEF improved from 30.2% ± 10.6% at baseline to 41.4% ± 11.3% at follow-up. These changes significantly correlated with those in the five echocardiographic indices, i.e., %RV fractional shortening (r = 0.27), %RV area change (r = 0.46), tricuspid annular plane systolic excursion (TAPSE) (r = 0.84), RV myocardial performance index (RVMPI) (r = -0.72), and systolic lateral tricuspid annular motion velocity (TVlat) (r = 0.66). Of these indices, %RV area change, TAPSE, and TVlat significantly correlated with those of CMRI-derived RVEF in both PAH and non-PAH subgroups. ROC analysis showed that improvement in echocardiographic indices predicted a pre-specified improvement in CMRI-derived RVEF (>2.9%), with TAPSE and TVlat showing better accuracy over the other three indices.
Conclusions: Echocardiographic indices modestly correlate with the changes in CMRI-derived RVEF in precapillary PH patients. Comparison among the five echocardiographic indices revealed that TAPSE and TVlat provide better accuracy than %RV fractional shortening, %RV area change, and RVMPI.
Conflict of interest statement
Figures



Similar articles
-
Validation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertension.J Am Soc Echocardiogr. 2012 Mar;25(3):280-6. doi: 10.1016/j.echo.2011.12.012. Epub 2012 Jan 9. J Am Soc Echocardiogr. 2012. PMID: 22230250
-
Serial assessment of right ventricular systolic function in patients with precapillary pulmonary hypertension using simple echocardiographic parameters: A comparison with cardiac magnetic resonance imaging.J Cardiol. 2017 Jan;69(1):182-188. doi: 10.1016/j.jjcc.2016.02.019. Epub 2016 Mar 22. J Cardiol. 2017. PMID: 27012754
-
The role of echocardiography for quantitative assessment of right ventricular size and function in adults with repaired tetralogy of Fallot.Congenit Heart Dis. 2019 Sep;14(5):700-705. doi: 10.1111/chd.12783. Epub 2019 May 9. Congenit Heart Dis. 2019. PMID: 31070871
-
Adaptive versus maladaptive right ventricular remodelling.ESC Heart Fail. 2023 Apr;10(2):762-775. doi: 10.1002/ehf2.14233. Epub 2022 Nov 23. ESC Heart Fail. 2023. PMID: 36419369 Free PMC article. Review.
-
Prognostic values of right ventricular echocardiography functional parameters for mortality prediction in precapillary pulmonary hypertension: a systematic review and meta-analysis.Egypt Heart J. 2024 Aug 14;76(1):105. doi: 10.1186/s43044-024-00539-6. Egypt Heart J. 2024. PMID: 39141268 Free PMC article. Review.
Cited by
-
Right ventricular systolic function in Nigerians with heart failure secondary to hypertensive heart disease.Afr Health Sci. 2019 Jun;19(2):2130-2139. doi: 10.4314/ahs.v19i2.37. Afr Health Sci. 2019. PMID: 31656497 Free PMC article.
-
MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension.Eur Radiol. 2021 Apr;31(4):1883-1893. doi: 10.1007/s00330-020-07287-6. Epub 2020 Sep 24. Eur Radiol. 2021. PMID: 32974687 Free PMC article.
-
Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension.Eur Respir Rev. 2020 Jul 3;29(156):190138. doi: 10.1183/16000617.0138-2019. Print 2020 Jun 30. Eur Respir Rev. 2020. PMID: 32620585 Free PMC article. Review.
-
Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis.Arthritis Res Ther. 2022 Jun 18;24(1):146. doi: 10.1186/s13075-022-02835-5. Arthritis Res Ther. 2022. PMID: 35717399 Free PMC article.
References
-
- Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011;140(1):19–26. Epub 2011/03/12. doi: 10.1378/chest.10-1166 ; PubMed Central PMCID: PMC3198486. - DOI - PMC - PubMed
-
- Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188(3):365–9. Epub 2013/04/23. doi: 10.1164/rccm.201209-1640OC ; PubMed Central PMCID: PMC3778730. - DOI - PMC - PubMed
-
- D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343–9. Epub 1991/09/01. . - PubMed
-
- McLure LE, Peacock AJ. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J. 2009;33(6):1454–66. Epub 2009/06/02. 33/6/1454 [pii] doi: 10.1183/09031936.00139907 . - DOI - PubMed
-
- Chin KM, Kingman M, de Lemos JA, Warner JJ, Reimold S, Peshock R, et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol. 2008;101(11):1669–72. Epub 2008/05/21. S0002-9149(08)00264-6 [pii] doi: 10.1016/j.amjcard.2008.01.055 . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical